Sign In
Buy BMRA
$1.49
-0.0999 (-6.28%)
At Close: Jul 31, 2026
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers
07:47am, Monday, 01'st Jul 2024
IRVINE, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, is proud to announce a major enhancement to its inFoods® IBS system,
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
08:19am, Monday, 13'th May 2024
IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products, today announced the init
IRVINE, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Biomerica Inc. (Nasdaq: BMRA), is proud to announce a multi-year exclusive distribution agreement with one of the UAE's most substantial healthcare c
Biomerica provides update on inFoods® IBS expansion
07:47am, Monday, 15'th Apr 2024
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas.
Biomerica Reports Third Quarter 2024 Financial Results
07:23pm, Friday, 12'th Apr 2024
IRVINE, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financia
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
08:19am, Thursday, 28'th Mar 2024
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company at the forefront of innovative gastroenterology solutions, proudly announces that data fr
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
08:19am, Wednesday, 21'st Feb 2024
Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Huff was the Former CEO of LabCor
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
08:19am, Tuesday, 23'rd Jan 2024
IRVINE, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment
Biomerica Reports Second Quarter 2024 Financial Results
08:19am, Tuesday, 16'th Jan 2024
IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial
IRVINE, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, today announced it has received U.S. Fo
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
08:19am, Friday, 10'th Nov 2023
IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14t
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
08:19am, Wednesday, 08'th Nov 2023
IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that several new Gastrointestinal (
REPEAT - Biomerica Reports First Quarter 2024 Financial Results
01:10pm, Friday, 13'th Oct 2023
Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate
Biomerica Reports First Quarter 2024 Financial Results
06:39am, Friday, 13'th Oct 2023
Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate
Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test
08:19am, Tuesday, 26'th Sep 2023
Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third most common cancer worldwide Simple 2 minute at-home test detects an early warning sign of colorectal cancer,
